Allison C. Rosenthal, D.O.

Location

Contact

SUMMARY

Allison C. Rosenthal, D.O., is a hematologist oncologist at Mayo Clinic specializing in lymphoma and adolescent and young adult oncology. Dr. Rosenthal is the clinical director of the CAR-T Cell Therapy Program in Arizona and medical director of the Mayo Clinic Comprehensive Cancer Center's Adolescent and Young Adult Cancer Program. Dr. Rosenthal's research interests include new therapeutic options for Hodgkin and non-Hodgkin lymphoma, survivorship issues, and supportive care research aimed at optimizing care for adolescent and young adult patients with cancer.

Focus areas

• New agents for Hodgkin lymphoma and non-Hodgkin lymphoma
• Survivorship and supportive care
• Caring for adolescents and young adults with cancer

Significance to patient care

Dr. Rosenthal's research focuses on improving care and outcomes for patients with Hodgkin and non-Hodgkin lymphoma. She makes these improvements by studying new treatments and treatment combinations and using them in the clinic. Dr. Rosenthal also strives to improve survivorship care by helping patients live well during and after treatment. She is especially committed to supporting adolescent and young adult patients, whose special needs often require specific care. By advancing treatment choices and support programs, Dr. Rosenthal's goal is to improve quality of life and long-term health for all patients facing lymphomas.

Professional highlights

• Clinical director, Cellular Therapy Program, Mayo Clinic in Arizona, 2024-present.
• Medical director, Adolescent and Young Adult Cancer Program, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic in Arizona, 2021-present.
• Member, American Society of Clinical Oncology, 2012-present.
• Member, American Society of Hematology, 2012-present.
• Lymphoma Research Foundation Scholar, 2019-2021.
• Woman of the Year, Leukemia and Lymphoma Society, 2017.